You just read:

Cardiovascular Drugs Markets, 2022 - Major Players are Daiichi Sankyo, J & J, Novartis, AstraZeneca, United Therapeutics, Gilead Sciences & Pfizer

News provided by

Research and Markets

Mar 27, 2018, 08:15 ET